Stilla Technologies rakes in $22 mn Series B

Stilla Technologies, a French provider of digital PCR solutions for high-precision genetic analysis, has raised $22 million in Series B funding.

Stilla Technologies, a French provider of digital PCR solutions for high-precision genetic analysis, has raised $22 million in Series B funding. The investors were TUS-Holdings, Illumina Ventures, Kurma Partners, LBO France, Paris Saclay Seed Funds, BNP Paribas Développement and Idinvest Partners.

Source: Press Release